Brunswick Corporation vs IDEXX Laboratories, Inc. — how do they compare? Brunswick Corporation trades at $77.96 (market cap $5.04B), while IDEXX Laboratories, Inc. trades at $550.52 (market cap $42.65B). The key difference: IDEXX Laboratories, Inc. is far larger — about 8.5× Brunswick Corporation's market cap, and Brunswick Corporation pays a 2.27% dividend while IDEXX Laboratories, Inc. pays none. Which is the better fit depends on your goals.
| BC | IDXX | |
|---|---|---|
Market Cap | $5.04B | $42.65B |
Sector | Consumer Cyclical | Health |
52-Week High | $89.22 | $766.68 |
52-Week Low | $56.64 | $514.61 |
Enterprise Value | $7.20B | $43.56B |
Dividend Yield | 2.27% | — |
Signals from Pluang's Aura AI — not financial advice
BC's stock trades at $76.95, down 1.22% on the day, with a bearish technical signal and support near $76. The company reported a net loss of $137.30 million in 2025 despite revenue of $5.36 billion, though recent earnings beat expectations. Analyst consensus is strongly bullish with a $86.40 price target, and the company continues expanding its Freedom Boat Club business.
The outlook is mixed: strong analyst support and operational cash flow of $562.10 million in 2025 provide upside potential, but negative profit margins and high P/E of 73.92 pose valuation risks. Investors face headwinds from profitability challenges despite positive sentiment from Wall Street.
IDXX trades at $564.09, up 0.09% with neutral technical signals. The stock shows strong fundamentals with revenue growth to $4.3B in 2025 and consistent earnings beats. Analyst consensus is bullish (59% Buy) with improving cash flow trends. Recent news highlights AI integration in medical devices and upcoming Q2 2026 earnings.
Outlook remains positive driven by innovation and market leadership in pet healthcare. Risks include high valuation multiples and competitive pressures. Institutional sentiment supports growth, but investors should monitor execution against elevated expectations.
Trailing returns across standard periods
Latest headlines on both assets
Brunswick Corp is the leader in several recreational sectors. The firm is the leading boat manufacturer, and its brands include Mercury and Mariner outboard engines
Read more on BC →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →